Redesign Health is a global venture and applied technology firm focused on building next-generation healthcare companies. We manage venture capital and venture buyout strategies, each powered by an AI operating system and team of leading technologists, entrepreneurs, and investors. Our venture capital strategy backs exceptional founders at the earliest stage—often before an idea is fully formed—and provides first institutional capital and an unmatched degree of strategic leverage and domain expertise through exit. Our venture buyout strategy partners with proven management teams through control investments and delivers outsized value by rewiring core products and workflows with AI. Since inception in 2018, Redesign and our portfolio companies have touched the lives of more than 15 million patients, raised over $1.5 billion from premier institutional, sovereign, and strategic investors, and built distinctive partnerships with marquee healthcare organizations and senior leaders around the world. Redesign is based in New York and has offices in Bengaluru, Los Angeles, and Riyadh. Most healthcare investors wait for companies to come to them. This role creates them. Redesign Health and Cedars-Sinai have launched a Digital Innovation Platform, a first-of-its-kind venture creation engine embedded inside one of the world’s premier academic medical centers. The platform combines Redesign’s healthcare company-building methodology with something no standalone venture firm can offer: Cedars-Sinai’s 4,500+ physicians and nurses, its expansive clinical network of 40+ hospitals and sites of care, a purpose-built synthetic and de-identified data platform, and a standing commitment to serve as the first customer for every company the platform creates. Ideas originate from the clinicians and researchers who see problems up close every day. The companies that emerge are validated in real clinical environments before they ever reach the broader market. This is an unparalleled opportunity to build generational healthcare companies. You will have something almost no one in healthcare venture has: a fully committed institutional partner with world-class clinical expertise, deep data assets, and the infrastructure to pilot and validate at scale - all before a company writes its first check to a customer. The access is real. The commitment is structural, not performative. As Managing Director, New Ventures, you will run Redesign’s side of this partnership end to end. This is a -1 to 0 role. Your job is to take clinical pain points and institutional white space and turn them into funded, founder-led operating companies. You will work inside Cedars-Sinai’s innovation infrastructure to surface high-conviction opportunities, develop original investment theses around them, attract exceptional founders, and shepherd concepts through co-ideation and diligence to Redesign’s Investment Committee. The right person for this role has built things before: companies, investment theses, teams, or programs in healthcare. You might come from venture capital, corporate venture, health system innovation, strategy, or operations. What matters more than your last title is that you have the commercial judgment to know which problems are worth solving, the taste to identify founding talent, and the credibility to be taken seriously by clinicians, executives, and entrepreneurs in the same week. You are the kind of person who earns trust inside institutions and moves with urgency once you have it. This position is based in Los Angeles. You get to be onsite 3–4 days per week in our Cedars-Sinai office.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director